Researchers report on a multinational, early phase clinical trial evaluating a new targeted therapy for patients with metastatic or unresectable non-small cell lung cancer who have a specific genetic mutation: EGFR Ex20Ins.
source https://www.sciencedaily.com/releases/2021/08/210803105526.htm
Wednesday, 4 August 2021
Related Posts
How recovery from COVID-19's impact on energy demand could help meet climate targetsThe pandemic-related drop in greenhouse gas emissions in 2020 was like… Read More
Seasonal variability in lakes’ environmental processes reveal susceptibility to climate changeA new study has shown how climate change could impact the ecosystems o… Read More
Excess deaths in people with mental health conditions increased during the COVID-19 pandemicThe greater number of deaths amongst those with mental health conditio… Read More
A rare feat: Material protects against both biological and chemical threatsResearchers have developed a versatile composite fabric that can deact… Read More
Greenland’s groundwater changes with thinning ice sheetFor more than a decade, a team of researchers and students have studie… Read More
New study sheds light on molecular motionNew research has shown how a synthetic self-made fibers can guide mole… Read More
0 comments: